Johnson Matthey PLC (LON:JMAT – Get Free Report) shares hit a new 52-week low during trading on Friday . The company traded as low as GBX 1,313 ($16.50) and last traded at GBX 1,313 ($16.50), with a volume of 136219 shares trading hands. The stock had previously closed at GBX 1,335 ($16.78).
Analyst Ratings Changes
A number of analysts have recently weighed in on the stock. Jefferies Financial Group reissued a “buy” rating and set a GBX 1,800 ($22.62) price target on shares of Johnson Matthey in a research report on Tuesday, December 17th. Berenberg Bank decreased their price objective on shares of Johnson Matthey from GBX 1,650 ($20.74) to GBX 1,500 ($18.85) and set a “hold” rating for the company in a report on Thursday, November 28th.
View Our Latest Report on JMAT
Johnson Matthey Stock Performance
Johnson Matthey Cuts Dividend
The firm also recently declared a dividend, which will be paid on Tuesday, February 4th. Stockholders of record on Thursday, December 5th will be issued a GBX 22 ($0.28) dividend. This represents a dividend yield of 1.47%. The ex-dividend date is Thursday, December 5th. Johnson Matthey’s dividend payout ratio (DPR) is presently 13,275.86%.
Insider Buying and Selling
In other Johnson Matthey news, insider Liam Condon purchased 27 shares of Johnson Matthey stock in a transaction on Wednesday, October 16th. The stock was bought at an average price of GBX 1,505 ($18.91) per share, for a total transaction of £406.35 ($510.68). Also, insider Stephen Oxley sold 19,554 shares of the firm’s stock in a transaction on Friday, October 18th. The shares were sold at an average price of GBX 1,526 ($19.18), for a total value of £298,394.04 ($375,008.22). Insiders have acquired a total of 7,458 shares of company stock worth $10,024,332 over the last quarter. 0.61% of the stock is owned by company insiders.
Johnson Matthey Company Profile
Johnson Matthey is a global leader in science that enables a cleaner and healthier world. With over 200 years of sustained commitment to innovation and technological breakthroughs, they improve the function, performance and safety of their customers’ products. Their science has a global impact in areas such as low emission transport, pharmaceuticals, chemical processing and making the most efficient use of the planet’s natural resources.
Further Reading
- Five stocks we like better than Johnson Matthey
- The 3 Best Fintech Stocks to Buy Now
- Oil Titans Face Off: Exxon Mobil or Chevron for 2025 Gains?
- How to Invest in Insurance Companies: A Guide
- Mining Stocks Back in the Spotlight: 3 Key Names to Watch
- Compound Interest and Why It Matters When Investing
- MarketBeat Week in Review – 12/16 – 12/20
Receive News & Ratings for Johnson Matthey Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Johnson Matthey and related companies with MarketBeat.com's FREE daily email newsletter.